D.C. Mun. Regs. tit. 17, r. 17-10001

Current through Register Vol. 71, No. 49, December 6, 2024

Rule 17-10001 - REQUIREMENTS FOR PARTICIPATION IN A COLLABORATIVE PRACTICE AGREEMENT

10001.1

A pharmacist shall only participate in a collaborative practice agreement in accordance with this chapter.

10001.2

A licensed physician shall have a valid patie nt-physician relationship with a patient that he or she refers to a pharmacist for participation in a collaborative practice agreement under this chapter.

10001.3

For purposes of this chapter, an internet based or telephone consultation or questionnaire evaluation is not adequate to establish a valid patient-physician relationship unless and except as otherwise specifically permitted by District law.

10001.4

The licensed physician and pharmacist who are parties to a collaborative practice agreement shall hold an active license in good standing in the District of Columbia.

10001.5

The Boards may deny approval of a physician or pharmacist to participate in a collaborative practice agreement if the physician or pharmacist has:

(a) A final order by the governing Board disciplining the physician or pharmacist's license for a practice issue within the five (5) years immediately preceding the formation of the agreement; or

(b) Limitations placed on the physician or pharmacist's license by the governing board.

10001.6

The collaborative practice agreement shall be within the scope of the licensed physician's current practice.

10001.7

To be eligible to participate in a collaborative practice agreement, a pharmacist:

(a) Shall possess relevant advanced training as indicated by one of the following:

(1) Certification as a specialist by:

(A) The Board of Pharmaceutical Specialties;

(B) The Commission for Certification in Geriatric Pharmacy; or

(C) Another credentialing body approved by the Board of Pharmacy; or

(2) Successful completion of:

(A) A residency accredited by the American Society of Health-Systems Pharmacists, a body approved by the Board of Pharmacy or offered by a body accredited by the Accreditation Council for Pharmacy Education; or

(B) A certificate program approved by the Board of Pharmacy; and

(b) Shall have successfully completed:

(1) A minimum of three (3) years of relevant clinical experience, if the pharmacist holds an academic degree of Doctor of Pharmacy; or

(2) A minimum of five (5) years of relevant clinical experience, if the pharmacist holds an academic degree of Bachelor of Science in Pharmacy; and

(c) Shall have documented training related to the area of practice covered by the collaborative practice agreement.

D.C. Mun. Regs. tit. 17, r. 17-10001

Final Rulemaking published at 65 DCR 8528 (8/17/2018)